Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Nagarajan Kannan, Ph.D., is combining cutting-edge technologies to study single cells, genetic approaches to track clones, and functional assays to quantify stem and progenitor cell numbers and their differentiation programs. Through his research in his Stem Cell and Cancer Biology Laboratory, Dr. Kannan hopes to identify cellular and molecular mechanisms that prevent or promote development of faulty progenitors in healthy epithelial tissues and their evolution into malignancies such as breast cancer.
Human breast malignancies are assumed to arise in epithelial stem and progenitor cells that acquire mutations. Dr. Kannan's work will lead to discovery of rare, cancer-prone faulty progenitor cells hidden in healthy breast tissues. This may allow for early detection and lead to preventive therapies for individuals with a higher risk of developing breast cancer.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.